Biologics News

LOS ANGELES — Use of intra-articular platelet-rich plasma significantly improved pain and function in patients with osteoarthritis at 6 months and may be a superior alternative to hyaluronic acid, according to study findings presented at the Arthroscopy Association of North America Annual Meeting.

Bacterin International Holdings recently announced the United States Patent and Trademark Office has issued the company U.S. Patent No. 8,992,964, entitled “Process for Demineralization of Bone Matrix with Preservation of Natural Growth Factors.”

BioStructures recently announced they have received FDA clearance for their new Silhouette MCS Bone Graft.

Orthopedics Today features eight stories and videos of importance to emerge from the American Academy of Orthopaedic Surgeons Annual Meeting.

SAN DIEGO — The rates of fusion following a minimally invasive transforaminal lumbar interbody fusion are directly affected by the choice of graft material, a speaker said here.

LAS VEGAS — Use of bone marrow concentrate containing mesenchymal stem cells as an adjunct therapy showed significant improvement in healing outcomes after rotator cuff repair, according to data presented during the American Academy of Orthopaedic Surgeons Annual Meeting.

LAS VEGAS — At the American Academy of Orthopaedic Surgeons Annual Meeting, Philippe Hernigou, MD, PhD, discusses his study on the role stem cells have in rotator cuff repair.

Editor’s note: In this article from the FORTE organization, Pinar Yilgor Huri, PhD, discusses the future of tissue engineering in orthopaedic surgery and successes to date in this area. Look for more articles from FORTE members in future issues of Orthopaedics Today Europe.

LAS VEGAS — A cohort of patients that underwent autologous conditioned plasma treatment exhibited similar reductions in epicondylitis pain to that seen in patients who received placebo injections, according to data presented at the American Academy of Orthopaedic Surgeons Annual Meeting.

KOLOA, Hawaii — According to Jason L. Dragoo, MD, the field of biologics will continue to grow, and the use of these products will become more popular in orthopedic practices.